Candriam Luxembourg S.C.A. »

Tango Therapeutics shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.0M 709k 8.40
2025-06-30 $3.6M 709k 5.12

More positions owned by Candriam Luxembourg S.C.A.

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Mastercard Incorporated Cl A (MA)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Palo Alto Networks (PANW)
Abbvie (ABBV)
Visa Com Cl A (V)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Tango Therapeutics

Trv Gp Iv
Farallon Capital Management
EcoR1 Capital
Boxer Capital Management
TCG Crossover Management
Woodline Partners
Siren
BlackRock
Nextech Invest
Vanguard Group
Gilead Sciences
T. Rowe Price Investment Management
Balyasny Asset Management
State Street Corporation
Paradigm Biocapital Advisors

View all funds holding Tango Therapeutics